On December 18, 2020, the Food and Drug Administration authorized the emergency use of the Moderna vaccine, exactly one week after granting the same to the vaccine developed by Pfizer and BioNTech. Two days later, the Advisory Committee on Immunization Practices (ACIP) has issued its recommendations for the next two phases of vaccine allocation.

Our guests are Michael D. Hogue, president of APhA, and a member of a working group of health care leaders that has been advising CDC on the rollout of the vaccine; and Stephan Foster. a member of ACIP, who has also served as a faculty member at the University of Tennessee’s School of Pharmacy and as a captain with the US Public Health Service.

Resources referenced in this podcast:

• FDA: Provider Guidance for the Moderna Vaccine (pdf)
• FDA: Patient information about the Moderna Vaccine (pdf)
• ACIP: Recommendations for Allocation Phase 1b and 1c (pdf)